Navigation Links
Cambrex To Announce Second Quarter 2009 Financial Results on August 4, 2009
Date:7/28/2009

EAST RUTHERFORD, N.J., July 28 /PRNewswire-FirstCall/ -- Cambrex Corporation (NYSE: CBM) announced that second quarter 2009 financial results will be released on Tuesday, August 4, 2009 after the market closes.

The Company will host a conference call to discuss the second quarter 2009 financial results.

                  Second Quarter 2009 Earnings Conference Call

    When:            Wednesday, August 5, 2009 at 8:30 a.m. Eastern Time

    Dial-in:         1-888-634-4003 for U.S.
                     1-706-634-6653 for International
                     Pass code:  21874877

    Dial-in Replay:  1-800-642-1687 for U.S.
                     1-706-645-9291 for International
                     Pass code:  21874877
                     Available through Wednesday, August 12, 2009

    Webcast:         www.cambrex.com
                     Available for 30 days following the conference call

About Cambrex

Cambrex provides products and services to accelerate the development and commercialization of small molecule therapeutics including active pharmaceutical ingredients ("API"), advanced intermediates, enhanced drug delivery, and other products for branded and generic pharmaceuticals. For more information, please visit www.cambrex.com.


'/>"/>
SOURCE Cambrex Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Cambrex Regains Compliance With Revised NYSE Listing Standards
2. Cambrex Reports Fourth Quarter and Full Year 2008 Results
3. Cambrex to Announce Fourth Quarter 2008 Financial Results on February 11, 2009
4. Skinvisible and Cambrex Enter Into Agreement to Develop Acne Products
5. Cambrex Presentation at The JPMorgan Healthcare Conference to be Webcast
6. Cambrex to Announce First Quarter 2008 Financial Results on May 1, 2008
7. Cambrex Customer Announced Recall
8. Cambrex Reports Fourth Quarter and Full-Year 2007 Results
9. Cambrex Signs Agreement To Acquire ProSyntest AS
10. Cambrex To Announce Third Quarter 2007 Financial Results on November 1, 2007
11. Inverness Medical Innovations Announces Second Quarter 2009 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... , ... IsoComforter, Inc. ( https://isocomforter.com ), one of the Nation’s ... design of the shoulder pad. The shoulder pad provides optimal support and full ... while using cold therapy. By utilizing ice and water that is circulated from an ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally recognized ... have expanded their existing home health joint venture through an agreement, effective October ... a joint venture home health company with Asante, delivering clinically integrated care, for ...
(Date:10/12/2017)... ... 12, 2017 , ... Dr. Parsa Mohebi, the Los Angeles ... to the newly revamped Cosmetic Town journal section, featuring articles written ... known as Follicular Unit Extraction (FUE). , Dr. Mohebi says “I ...
(Date:10/12/2017)... ... ... Leading pediatric oncology experts at Children’s National Health System will join ... International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by Jeffrey Dome, ... at Children’s National, and Stephen P. Hunger, M.D., Chief of the Division of ...
(Date:10/12/2017)... ... 12, 2017 , ... Women-owned and Grand Rapids-based workplace wellness ... in Wellness® by Best and Brightest. OnSite Wellness will be honored at the ... 7:30 a.m. to 2 p.m. at the Henry Autograph Collection Hotel, located at ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... 2017 West Pharmaceutical Services, Inc. ... injectable drug administration, today announced that it will release ... Thursday, October 26, 2017, and will follow with a ... at 9:00 a.m. Eastern Time. To participate on the ... conference ID is 94093362. ...
(Date:10/11/2017)... , Oct. 11, 2017  True Health, a ... amplified its effort during National Breast Cancer Awareness ... cancer risks. ... Oncology calculated that more than 10 million American ... mutations in BRCA1 or BRCA2 and have not had ...
(Date:10/10/2017)...   West Pharmaceutical Services, Inc. (NYSE: WST), ... administration, today shared the results of a study highlighting ... intradermal administration of polio vaccines. The study results were ... 2017 by Dr. Ondrej Mach , Clinical Trials ... (WHO), and recently published in the journal Vaccine. ...
Breaking Medicine Technology: